HouseH.R. 10370119th Congress
To better coordinate Federal efforts to utilize advance technologies, such as artificial intelligence, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.
Full Text
Official text as published. Use Ctrl+F / Cmd+F to search within the document.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10370 Introduced in House (IH)]
<DOC>
119th CONGRESS
2d Session
H. R. 10370
To better coordinate Federal efforts to utilize advance technologies,
such as artificial intelligence, to improve diagnoses, treatments,
cures, and prevention strategies for pediatric cancer, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 14, 2026
Mr. McCaul (for himself, Mr. Bera, and Mr. Kelly of Pennsylvania)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To better coordinate Federal efforts to utilize advance technologies,
such as artificial intelligence, to improve diagnoses, treatments,
cures, and prevention strategies for pediatric cancer, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``Ailani Myers
Accelerating Innovation in Medicine to Cure Kids with Cancer Act'' or
the ``Ailani Myers AIM to Cure Kids with Cancer Act''.
(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; table of contents.
TITLE I--FEDERAL GOVERNMENT EFFORTS
Sec. 101. Coordination of Federal efforts.
TITLE II--DEPARTMENT OF HEALTH AND HUMAN SERVICES EFFORTS
Sec. 201. Childhood cancer data initiative.
Sec. 202. Harnessing innovation in artificial intelligence.
Sec. 203. Improving the data ecosystem, data sharing, and empowering
patients.
Sec. 204. Reports.
TITLE III--GENERAL PROVISIONS
Sec. 301. Definitions.
Sec. 302. Privacy.
Sec. 303. Authorization of appropriations.
Sec. 304. Rule of construction.
TITLE I--FEDERAL GOVERNMENT EFFORTS
SEC. 101. COORDINATION OF FEDERAL EFFORTS.
(a) In General.--The President shall designate an officer or
employee of the Federal Government, or an office, council, or
commission of the executive branch, to coordinate Federal efforts to
use advanced technologies, including artificial intelligence, to
improve the diagnosis, treatment, and prevention of, and the
development of cures for, pediatric cancer. The officer, employee,
office, council, or commission so designated shall be known as the
Coordinator of AI Innovation (in this Act referred to as the
``Coordinator'').
(b) Notification.--Not later than 30 days after making a
designation under subsection (a), the President shall notify the
appropriate committees of Congress of the designation.
(c) Duties.--The Coordinator shall--
(1) coordinate and align the activities of relevant Federal
departments and agencies, in support of the purposes specified
in subsection (a), including--
(A) the Department of Health and Human Services,
and the agencies and offices thereof, including--
(i) the National Institutes of Health;
(ii) the Food and Drug Administration;
(iii) the Centers for Medicare & Medicaid
Services;
(iv) the Advanced Research Projects Agency
for Health; and
(v) the Office of the National Coordinator
for Health Information Technology;
(B) the Department of Defense, including the
Defense Health Agency and the Congressionally Directed
Medical Research Programs;
(C) the Department of Energy;
(D) the Department of Veterans Affairs;
(E) the National Science Foundation;
(F) the National Institute of Standards and
Technology;
(G) the Office of Science and Technology Policy;
and
(H) such other Federal departments and agencies as
the Coordinator determines appropriate;
(2) facilitate, with respect to the Federal efforts
relating to pediatric cancer specified in subsection (a),
interagency coordination and collaboration among Federal and
non-Federal entities, such as patients, survivors, families,
caregivers, researchers, and entities funding research on
pediatric cancer;
(3) align Federal data and artificial intelligence policies
affecting pediatric cancer research and care;
(4) consult with the Director of the National Cancer
Institute on matters affecting the CCDI; and
(5) support the Federal activities that advance the
purposes of this Act, including the activities of the CCDI.
TITLE II--DEPARTMENT OF HEALTH AND HUMAN SERVICES EFFORTS
SEC. 201. CHILDHOOD CANCER DATA INITIATIVE.
(a) In General.--The NCI Director shall carry out the CCDI to
collect, generate, standardize, link, and share data with respect to
individuals who are diagnosed with cancer as a child, adolescent, or
young adult, regardless of the age of the individual on the date such
data is collected, regardless of where such individual receives care,
in order to improve outcomes for individuals with such cancers,
including with respect to prevention, diagnosis, treatment, quality of
life, and survivorship.
(b) Components.--In carrying out subsection (a), the NCI Director--
(1) shall support, at a minimum--
(A) molecular characterization of pediatric
cancers, including through the initiative known as the
Molecular Characterization Initiative of the CCDI, and
the sharing of the results of such characterization to
inform diagnosis and treatment;
(B) the generation, analysis, and sharing of data
produced by non-invasive clinically validated
technologies, software, and artificial intelligence
tools, including molecular testing and functional
precision medicine approaches, to inform diagnosis and
treatment;
(C) data platforms, catalogs, and tools that enable
researchers and clinicians to find, access, integrate,
analyze, and share pediatric cancer data, including the
network of such platforms and tools known as the CCDI
Data Ecosystem;
(D) the collection and study of data on pediatric
cancers, including rare pediatric cancers;
(E) the aggregation and linkage of clinical,
research, and population-based data for secondary use,
including through the registry known as the National
Childhood Cancer Registry; and
(F) the development of data standards and
infrastructure necessary to carry out subparagraphs (A)
through (D); and
(2) may support such other activities as the NCI Director
determines appropriate to carry out subsection (a).
(c) Director of the CCDI.--The Secretary, on the recommendation of
the NCI Director, shall designate a Director of the Childhood Cancer
Data Initiative (in this Act referred to as the ``CCDI Director''), who
shall--
(1) be an individual with demonstrated scientific expertise
in pediatric oncology, biomedical data science, or a related
field;
(2) provide scientific and programmatic leadership for the
CCDI, including the components described in subsection (b) and
the artificial intelligence activities described in section
202;
(3) coordinate the activities of the CCDI with other
Federal departments and agencies and with non-Federal partners;
and
(4) report to the NCI Director.
SEC. 202. HARNESSING INNOVATION IN ARTIFICIAL INTELLIGENCE.
(a) In General.--The NCI Director shall support, in coordination
with the Coordinator, the development and application of artificial
intelligence to accelerate progress in pediatric cancer research and
care, including through the CCDI.
(b) Data Readiness.--In carrying out subsection (a), the NCI
Director shall--
(1) expand and improve the artificial intelligence
readiness of the data platforms and tools of the CCDI Data
Ecosystem;
(2) consolidate and harmonize data from multiple sources to
enable such data to be analyzed using artificial intelligence;
and
(3) develop data standards and technical approaches
necessary for the use of artificial intelligence with the data
described in paragraphs (1) and (2).
(c) Research and Analysis.--In carrying out subsection (a), the NCI
Director shall support research on pediatric cancer using artificial
intelligence--
(1) to improve predictive modeling of patient response,
disease progression, and treatment toxicity;
(2) to derive novel diagnostic, prognostic, and therapeutic
biomarkers from molecular and imaging data; and
(3) to carry out research projects, including projects
carried out at cancer centers designated by the National Cancer
Institute.
(d) Clinical Trials.--In carrying out subsection (a), the Secretary
shall support the use of multimodal data and artificial intelligence to
improve the design, participant recruitment and selection,
administration, conduct, and interpretation of clinical trials for
medical products intended to diagnose, treat, prevent, or cure
pediatric cancer.
(e) Relationship to CCDI Components.--Activities under this section
shall supplement, and not supplant, the components described in section
201(b).
(f) Dissemination.--The Secretary shall make methods, tools, data
standards, and technical approaches developed under this section
available to other programs of the National Cancer Institute, to other
Federal departments and agencies, and, as appropriate, to the public.
SEC. 203. IMPROVING THE DATA ECOSYSTEM, DATA SHARING, AND EMPOWERING
PATIENTS.
(a) Integration of Artificial Intelligence Into Interoperability.--
The Secretary of Health and Human Services, acting through the National
Coordinator for Health Information Technology, shall ensure that
artificial intelligence is appropriately integrated into
interoperability activities carried out under title XXX of the Public
Health Service Act (42 U.S.C. 300jj et seq.), in order to improve the
potential for electronic health record and claims data to inform
private sector and academic research and clinical trial design, while
ensuring the privacy of individually identifiable health information in
accordance with regulations promulgated under section 264(c) of the
Health Insurance Portability and Accountability Act of 1996 (42 U.S.C.
1320d-2 note).
(b) Interoperability Standards.--Not later than 2 years after the
date of the enactment of this Act, the Secretary, acting through the
National Coordinator for Health Information Technology, shall finalize
interoperability standards for patient data to be used with artificial
intelligence that--
(1) appropriately account for structured and unstructured
data;
(2) enable safe and privacy-compliant exchanges of data;
and
(3) account for the needs of pediatric patients, including
pediatric cancer patients, as a priority use case.
(c) Applicability.--The standards finalized under subsection (b)
shall be developed for application throughout the Department of Health
and Human Services and shall not be limited in application to the CCDI
or to the National Cancer Institute.
(d) Consultation and Patient Engagement.--In carrying out this
section, the Secretary, acting through the National Coordinator for
Health Information Technology, shall--
(1) consult with the Director, the CCDI Director, patients
and their families, health care providers, researchers, and
developers of health information technology;
(2) coordinate with the patient community to ensure
transparency and to establish mechanisms for the sharing of
data; and
(3) identify existing barriers to pediatric data sharing
and interoperability, in coordination with the stakeholder
community, and make recommendations to address such barriers.
SEC. 204. REPORTS.
(a) Interim Report.--Not later than 180 days after the date of the
enactment of this Act, the Secretary of Health and Human Services shall
submit to the appropriate committees of Congress a report that--
(1) describes the progress made in implementing this title;
(2) includes any interim findings of the Secretary with
respect to that implementation; and
(3) identifies any barriers to that implementation.
(b) Annual Reports.--Not later than 1 year after the date of the
enactment of this Act, and annually thereafter through fiscal year
2031, the Secretary of Health and Human Services shall submit to the
appropriate committees of Congress a report that includes--
(1) a description of the activities carried out under this
title, including each component described in section 201(b) and
the artificial intelligence activities described in section
202;
(2) the amounts expended on such activities;
(3) progress on data sharing, interoperability, and privacy
protections, including the status of the interoperability
standards required under section 203(b);
(4) the barriers identified in section 203(d)(3) and the
recommendations made to address such barriers; and
(5) outcomes and measures of progress with respect to the
diagnosis, treatment, prevention, or cure of pediatric cancer.
TITLE III--GENERAL PROVISIONS
SEC. 301. DEFINITIONS.
In this Act:
(1) Appropriate committees of congress.--The term
``appropriate committees of Congress'' means--
(A) the Committee on Energy and Commerce of the
House of Representatives;
(B) the Committee on Science, Space, and Technology
of the House of Representatives;
(C) the Committee on Health, Education, Labor, and
Pensions of the Senate; and
(D) the Committee on Commerce, Science, and
Transportation of the Senate.
(2) Artificial intelligence.--The term ``artificial
intelligence'' has the meaning given such term in section
238(g) of the John S. McCain National Defense Authorization Act
for Fiscal Year 2019 (Public Law 115-232).
(3) CCDI.--The term ``CCDI'' means the initiative known as
the Childhood Cancer Data Initiative.
(4) NCI director.--The term ``NCI Director'' means the
Director of the National Cancer Institute.
SEC. 302. PRIVACY.
Activities under this Act shall be carried out in a manner
consistent with applicable Federal and State laws relating to the
privacy of patient information, including the regulations promulgated
under section 264(c) of the Health Insurance Portability and
Accountability Act of 1996 (42 U.S.C. 1320d-2 note).
SEC. 303. AUTHORIZATION OF APPROPRIATIONS.
(a) In General.--There are authorized to be appropriated to carry
out this Act, other than section 201, such sums as may be necessary for
each of fiscal years 2027 through 2031.
(b) CCDI.--In addition to amounts authorized to be appropriated
under subsection (a), there are authorized to be appropriated to carry
out section 201 $100,000,000 for each of fiscal years 2027 through
2031.
SEC. 304. RULE OF CONSTRUCTION.
Nothing in this Act shall be construed to affect the authority of
the Secretary of Health and Human Services or the Director of the
National Cancer Institute under any other provision of Federal law.
<all>